FDA panel recommends against gabapentin’s approval for hot flashes – Ob.Gyn. News Digital Network

by admin on March 5, 2013

FDA panel recommends against gabapentin's approval for hot flashes
Ob.Gyn. News Digital Network
in 1993 as an adjunctive treatment of partial seizures, and has been used off label for vasomotor symptoms. Gabapentin encarbil, a prodrug of gabapentin, marketed as Horizant, was approved in 2011 for restless legs syndrome and postherpetic neuralgia.

and more »

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: